Teratogenicity and embryotoxicity of thalidomide and 3-aza-thalidomide in mice.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D001372:Aza Compounds / Q000008:administration & dosage / Q000633:toxicity; D001835:Body Weight / Q000187:drug effects; D001842:Bone and Bones / Q000002:abnormalities; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D010064:Embryo Implantation / Q000187:drug effects; D005260:Female; D005313:Fetal Death / Q000139:chemically induced; D005333:Fetus / Q000187:drug effects; D005865:Gestational Age; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D051379:Mice; D008815:Mice, Inbred Strains; D011247:Pregnancy; D013329:Structure-Activity Relationship; D013792:Thalidomide / Q000008:administration & dosage / Q000032:analysis* / Q000633:toxicity*
D001372:Aza Compounds; D013792:Thalidomide